The new generation of weight-loss drugs
These drugs imitate a hormone known as GLP-1 (it stands for glugacon-like peptide-1), which is secreted by the intestines. It stimulates insulin production and creates a feeling of fullness, suppressing the appetite.
PREMIUM Health
Illustration of an inactivated glucagon-like peptide-1 (GLP-1) receptor (blue) surrounded by semaglutide agonists (red). (AFP)
NewVision Reporter
@NewVision
_____________
Paris, France | AFP
Wegovy, Mounjaro, Ozempic... These new drugs drawing such intense attention have raised the hopes of millions around the world suffering from diabetes or